Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers
Sandra Misale(IFOM), Alberto Bardelli(Candiolo Cancer Institute)
Cited by 128
Related Papers
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets
|Nature Communications|2015|305
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial
|Nature Medicine|2022|251
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
|Nature Communications|2016|211
Exploiting <scp>DNA</scp> repair defects in colorectal cancer
|Molecular Oncology|2019|134
TGFα and Amphiregulin Paracrine Network Promotes Resistance to EGFR Blockade in Colorectal Cancer Cells
|Clinical Cancer Research|2014|114